Markets:

Overview

News

Currencies

International

Treasuries

Prime Medicine, Inc. - Common Stock (NQ:PRME)

4.445 -0.275 (-5.83%)

Delayed Quote Updated: 1:25 PM EST, Nov 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Prime Medicine, Inc. - Common Stock

< Previous 1 2 3 Next >

Ocular Therapeutix vs. Prime Medicine: Which Healthcare Stock Is a Better Buy in 2026? ↗

June 15, 2026

Two biotech innovators, two very different risk profiles: one with commercial products and another betting on next-gen gene editing breakthroughs.

Via The Motley Fool

Prime Medicine (NASDAQ:PRME) Q1 Results Show Revenue Miss and Narrower Loss as Key Pipeline Milestones Loom ↗

May 07, 2026

Via Chartmill

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 15, 2025

Via Benzinga

Generative AI Unleashes a New Era in Genome Editing, Outperforming Nature in Protein Design

October 02, 2025

London, UK – October 2, 2025 – In a monumental stride for biotechnology and medicine, generative artificial intelligence (AI) has achieved a scientific breakthrough, demonstrating an unprecedented...

Via TokenRing AI

Topics Artificial Intelligence

My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years ↗

September 18, 2025

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds of billions dollars in revenue.

Via Benzinga

Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday ↗

September 03, 2025

Via Benzinga

PRME Revenue Misses by 73% ↗

August 07, 2025

Via The Motley Fool

Align Technology Posts Downbeat Earnings, Joins Confluent,FormFactor And Other Big Stocks Moving Lower In Thursday Pre-Market Session ↗

July 31, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 31, 2025

Via Benzinga

Why Meta Platforms Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗

July 31, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 30, 2025

Via Benzinga

Galaxy Digital, Blaize Holdings, Verizon And Other Big Stocks Moving Higher On Monday ↗

July 21, 2025

Via Benzinga

KalVista Pharmaceuticals, Cogent Biosciences, WNS And Other Big Stocks Moving Higher On Monday ↗

July 07, 2025

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

July 02, 2025

Via Benzinga

Hut 8, Greenbrier And Other Big Stocks Moving Higher On Tuesday ↗

July 02, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 17, 2025

Via Benzinga

Citi Downgrade Sparks Retail Chatter On Prime Medicine Amid Cash Runway Uncertainty ↗

May 27, 2025

The biotech firm announced a restructuring to focus on its liver disease programs while cutting costs and workforce amid ongoing development challenges.

Via Stocktwits

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 22, 2025

Via Benzinga

This MongoDB Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗

May 20, 2025

Via Benzinga

6 Analysts Assess Prime Medicine: What You Need To Know ↗

May 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 19, 2025

Via Benzinga

Prime Medicine Announces Layoffs, CEO Transition: Retail Gets More Bullish ↗

May 19, 2025

The company said Keith Gottesdiener will step down as the chief executive, while CFO Allan Reine will succeed him.

Via Stocktwits

Topics Workforce

Cathie Wood's Ark Invest Offloads Uipath, Prime Medicine, And Repare Therapeutics ↗

April 11, 2025

On April 11th, 2025, Cathie Wood's Ark Invest sold shares in UiPath, Prime Medicine, and Repare Therapeutics, with notable gains and losses.

Via Benzinga

Why Prime Medicine Stock Was Climbing Higher This Week ↗

March 20, 2025

Via The Motley Fool

Why Prime Medicine Stock Is Soaring Today ↗

March 19, 2025

Via The Motley Fool

Cathie Wood's Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibotta ↗

March 15, 2025

Ark Invest's Cathie Wood-led funds made significant trades involving GitLab, Intellia, Prime Medicine, UiPath, Ibotta, Roblox, Repare Therapeutics, and CareDx.

Via Benzinga

12 High-Growth Stocks That Could Deliver Parabolic Returns ↗

October 28, 2024

These 12 innovative companies could deliver exponential returns over the next quarter century.

Via The Motley Fool

Why I Keep Buying These 14 Incredible Growth Stocks ↗

October 16, 2024

This diverse set of growth stocks offers tremendous opportunities in the fields of AI, space, biotech, and emerging industries.

Via The Motley Fool

Topics Artificial Intelligence

Why Prime Medicine Stock Soared Nearly 12% Higher on Monday ↗

September 30, 2024

Changes are afoot at the company, and investors welcomed them.

Via The Motley Fool

Dow Dips 300 Points; Emcore Shares Spike Higher ↗

September 30, 2024

Via Benzinga

Topics Stocks

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.